All posts tagged Moderna
Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates
March 13, 2021 | No comments
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participants […]
Read more »
European Commission Purchases Additional 150 Million Doses of COVID-19 Vaccine Moderna
February 18, 2021 | No comments
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Commission […]
Read more »
Moderna European Distribution Update
January 11, 2021 | No comments
Deliveries of COVID-19 vaccine to EU and EEA Member States to begin on Monday, January 11, 2021 Moderna Switzerland GmbH, […]
Read more »
Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel
January 5, 2021 | No comments
Ministry of Health of Israel has secured 6 million doses and first deliveries expected to begin in January Moderna, Inc. (Nasdaq: […]
Read more »
Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents
December 11, 2020 | No comments
Phase 2/3 study expected to enrol 3,000 healthy participants Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) […]
Read more »
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate
December 8, 2020 | No comments
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of […]
Read more »
Moderna applies for conditional approval from European Medicines Agency
December 3, 2020 | No comments
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]
Read more »
Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
October 26, 2020 | No comments
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of […]
Read more »